Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Alnylam reports results from Phase 2 revusiran trial
Alnylam reports results from Phase 2 revusiran trial
Alnylam reports results from Phase 2 revusiran trial
Submitted by
admin
on November 14, 2014 - 9:54am
Source:
Seeking Alpha
News Tags:
Alnylam
revusiran
TTR cardiac amyloidosis
RNAi
Headline:
Alnylam reports results from Phase 2 revusiran trial
Do Not Allow Advertisers to Use My Personal information
